Techcyte Inc News Today

/PRNewswire/ -- The "AI in Pathology Market by Component (Software, Scanners), Neural Network (CNN, GAN, RNN), Application (Drug Discovery, Diagnosis,...

Techcyte, the world leader in AI-based cellular digital diagnostics, is pleased to announce a collaboration with CompuMed to enhance the digital manual review of available livers and kidneys for organ transplantation. As

CompuMed Integrates the Techcyte Digital Pathology Reviewing Platform ...

"In April 2023, Indica Labs Inc. (US) signed an agreement with Lunit Inc. (South Korea). The agreement helped to provide a fully interoperable solution between Indica Labs' HALO AP image management software platform and

During the forecast period. The AI in pathology market refers to the sector within the healthcare industry that encompasses the development, deployment,...

/PRNewswire/ -- In the near future, the AI in pathology industry is poised to revolutionize the field of diagnostics and patient care. Advancements in machine...

Techcyte, the leading provider of advanced AI, workflow and digital diagnostics solutions, is thrilled to announce the remarkable achievement of performing two

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI-Based Digital Pathology Solutions Market By...

Techcyte, the clinical pathology AI platform, is proud to congratulate its partner, NanoSpot.ai, on entering into a commercial and distribution agreement with

/PRNewswire/ -- Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems, is working with Techcyte, a leading provider of a clinical...